August 12, 2025 10:03am
ADVM opened up +$0.02 or +0.90% to $2.26 having closed down -$0.05 <Monday>
Sale of approximately $10 M of its common and pre-funded warrants to Frazier Life Sciences
ADVM announced that it has agreed to sell approximately $10 M of its common stock and pre-funded warrants in a private investment in public equity ("PIPE") financing at a purchase price of $2.24 per share or $2.2399 per pre-funded warrant, representing the closing price on August 11, 2025.
- The pre-funded warrants will have an exercise price of $0.0001 per share of common stock.
- The PIPE is expected to close on August 12, 2025, subject to customary closing conditions. There was no placement agent associated with this offering.
The Bottom Line: Done is done ...
- 52 Week Change -66.86%
- S&P 500 52-Week Change 17.28%
- 52 Week High $8.5600
- 52 Week Low $1.7800
- 50-Day Moving Average 2.5020
- 200-Day Moving Average 4.1672
- Avg Vol (3 month) 249.76k
- Avg Vol (10 day) 103.94k
- Shares Outstanding 20.89M
- Implied Shares Outstanding 6 20.89M
- Float 8 12.28M
- % Held by Insiders 13.10%
- % Held by Institutions 69.04%
- Shares Short (7/31/2025) 986.34k
- Short Ratio (7/31/2025) 7.34
- Short % of Float (7/31/2025) 5.39%
